Robert M. Whelan Jr., Director at Annovis Bio, Inc. (ANVS), bought 95,700 shares at $6.00 ($204K) on 2020-01-31, disclosed to the SEC on 2020-02-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 59,524 | $0 | 0.0% |
| 2 | $4.80 | 11,176 | $54K | 26.3% |
| 3 | $6.00 | 25,000 | $150K | 73.7% |
| Total | $2.13 avg | 95,700 | $204K | 100% |
| Filing → |
| AZPN | SELL | 2023-06-14 | $1.0M | — | Filing → |
| AZPN | SELL | 2022-05-13 | $1.3M | — | Filing → |
| AZPN | SELL | 2021-05-28 | $2.5M | — | Filing → |